ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Proteomic Profiling of Alveolar Macrophages Identifies Loss of Lysosomal Content as an Indicator of Nanofiber-Induced Frustrated Phagocytosis.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Toxicological research on inhalable fibers, such as asbestos, has identified material morphology (i.e., length and diameter) and bio-persistence as drivers of adverse health effects (e.g., fibrosis, lung cancer, mesothelioma). Although nanofibers may meet these criteria, their small diameters may enable them to adopt different shapes, affecting their toxicity. While nanofiber pathogenicity is still assessed using animal models, the development of alternative in vitro methods relies on a mechanistic understanding of toxicity. Here, we address nanofiber-induced protein changes in alveolar macrophages by analyzing whole cell lysates and supernatants of NR8383 cells exposed to silicon carbide nanofibers, Mitsui-7 carbon nanotubes, and Printex-90. While all materials elicited a similar dose-dependent cytotoxicity, there was a nanofiber-specific release of TNF-α and glucuronidase. Proteomic profiling after treatment with low, non-cytotoxic concentrations confirmed the inflammatory response and revealed a release of 20 lysosomal, luminal hydrolases, including six cathepsins, into the extracellular supernatant. In cell lysates, these hydrolases were decreased, while membrane-associated lysosomal proteins remained unchanged, suggesting that macrophages engulfing long nanofibers release lysosomal content from open membrane pouches during frustrated phagocytosis. Additionally, 17 biomarkers of nanofiber-induced toxicity were identified as potential targets for predictive, animal-free screening. These early markers may be of value for assessing nanofiber toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.